BPO-27, a benzopyrimido-pyrrolo-oxazine-dione analog, is a novel, potent CFTR inhibitor with IC50 of 4 nM. It can be potentially used as a therapeutic for secretory diarrheas and ADPKD because of its druglike properties and low-nanomolar potency for inhibition of CFTR chloride conductance.

纯度：≥98%

CAS：1415390-47-4